Meta-analysis of proton pump inhibitors induced risk of community-acquired pneumonia

被引:29
|
作者
Phung Anh Nguyen [1 ]
Islam, Mohaimenul [1 ,2 ]
Galvin, Cooper J. [1 ]
Chang, Chih-Cheng [3 ,4 ]
An, Soo Yeon [5 ]
Yang, Hsuan-Chia [4 ]
Huang, Chih-Wei [1 ]
Li, Yu-Chuan [1 ,4 ,6 ]
Iqbal, Usman [1 ,7 ]
机构
[1] Taipei Med Univ, Coll Med Sci & Technol, Int Ctr Hlth Informat Technol, Taipei 11031, Taiwan
[2] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Biomed Informat, Taipei 11031, Taiwan
[3] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Pulm Med, New Taipei 235, Taiwan
[4] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei 11031, Taiwan
[5] Chungnam Natl Univ Hosp, Dept Cardiol, Daejeon 35015, South Korea
[6] Wan Fang Hosp, Dept Dermatol, Taipei 116, Taiwan
[7] Taipei Med Univ, Coll Publ Hlth, Global Hlth & Dev Dept, Global Hlth & Hlth Secur, Taipei 11031, Taiwan
关键词
clinical study; epidemiology; gastrointestinal diseases; pneumonia; proton pump inhibitors; OBSTRUCTIVE PULMONARY-DISEASE; STRESS-ULCER; ADULTS; HOSPITALIZATION; PREVENTION; MANAGEMENT; DIAGNOSIS; THERAPY;
D O I
10.1093/intqhc/mzaa041
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose: Proton pump inhibitors (PPIs), one of the most widely used medications, are commonly used to suppress several acid-related upper gastrointestinal disorders. Acid-suppressing medication use could be associated with increased risk of community-acquired pneumonia (CAP), although the results of clinical studies have been conflicting. Data sources: A comprehensive search of MEDLINE, EMBASE and Cochrane library and Database of Systematic Reviews from the earliest available online year of indexing up to October 2018. Study selection: We performed a systematic review and meta-analysis of observational studies to evaluate the risk of PPI use on CAP outcomes. Data extraction: Included study location, design, population, the prevalence of CAP, comparison group and other confounders. We calculated pooled odds ratio (OR) using a random-effects meta-analysis. Results of data synthesis: Of the 2577 studies screening, 11 papers were included in the systematic review and 7 studies with 65 590 CAP cases were included in the random-effects meta-analysis. In current PPI users, pooled OR for CAP was 1.86 (95% confidence interval (CI), 1.30-2.66), and in the case of recent users, OR for CAP was 1.66 (95% CI, 1.22-2.25). In the subgroup analysis of CAP, significance association is also observed in both high-dose and low-dose PPI therapy. When stratified by duration of exposure, 3-6 months PPIs users group was associated with increased risk of developing CAP (OR, 2.05; 95% CI, 1.22-3.45). There was a statistically significant association between the PPI users and the rate of hospitalization (OR, 2.59; 95% CI, 1.83-3.66). Conclusion: We found possible evidence linking PPI use to an increased risk of CAP. More randomized controlled studies are warranted to clarify an understanding of the association between PPI use and risk of CAP because observational studies cannot clarify whether the observed epidemiologic association is a causal effect or a result of unmeasured/residual confounding.
引用
收藏
页码:292 / 299
页数:8
相关论文
共 50 条
  • [31] Associations between Community-Acquired Pneumonia and Proton Pump Inhibitors in the Laryngeal/Voice-Disordered Population
    Cohen, Seth M.
    Lee, Hui-Jie
    Leiman, David A.
    Roy, Nelson
    Misono, Stephanie
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2019, 160 (03) : 519 - 525
  • [32] Efficacy and Safety of Corticosteroid Therapy for Community-Acquired Pneumonia: A Meta-Analysis and Meta-Regression of Randomized, Controlled Trials
    Bergmann, Felix
    Pracher, Lena
    Sawodny, Rebecca
    Blaschke, Amelie
    Gelbenegger, Georg
    Radtke, Christine
    Zeitlinger, Markus
    Jorda, Anselm
    CLINICAL INFECTIOUS DISEASES, 2023, 77 (12) : 1704 - 1713
  • [33] Chlamydia psittaci (psittacosis) as a cause of community-acquired pneumonia: a systematic review and meta-analysis
    Hogerwerf, L.
    De Gier, B.
    Baan, B.
    Van der Hoek, W.
    EPIDEMIOLOGY AND INFECTION, 2017, 145 (15) : 3096 - 3105
  • [34] Proton Pump Inhibitors Use and Risk of Preeclampsia: A Meta-Analysis
    Hussain, Salman
    Singh, Ambrish
    Antony, Benny
    Klugarova, Jitka
    Murad, M. Hassan
    Jayraj, Aarthi S.
    Langaufova, Alena
    Klugar, Miloslav
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (16)
  • [35] Macrolide-Based Regimens and Mortality in Hospitalized Patients With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis
    Asadi, Leyla
    Sligl, Wendy I.
    Eurich, Dean T.
    Colmers, Isabelle N.
    Tjosvold, Lisa
    Marrie, Thomas J.
    Majumdar, Sumit R.
    CLINICAL INFECTIOUS DISEASES, 2012, 55 (03) : 371 - 380
  • [36] Predictive roles of D-dimer for mortality of patients with community-acquired pneumonia: a systematic review and meta-analysis
    Yang, Cheng
    Zeng, Han-Hua
    Huang, Juan
    Zhang, Qian-Yun
    Lin, Kun
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2021, 47 (06)
  • [37] Proton-pump inhibitor use and risk of community-acquired pneumonia in congenital heart disease patients
    Evers, Patrick D.
    Farkas, Dora K.
    Khoury, Michael
    Olsen, Morten
    Madsen, Nicolas L.
    INTERNATIONAL JOURNAL OF CARDIOLOGY CONGENITAL HEART DISEASE, 2021, 4
  • [38] Etiology of Community-Acquired Pneumonia in Hospitalized Patients in Northern Israel
    Shibli, Fahmi
    Chazan, Bibiana
    Nitzan, Orna
    Flatau, Edit
    Edelstein, Hana
    Blondheim, Orna
    Raz, Raul
    Colodner, Raul
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2010, 12 (08): : 477 - 482
  • [39] Corticosteroids in the Treatment of Severe Community-Acquired Pneumonia
    Ramsey, Tasha D.
    Gorman, Sean K.
    CURRENT INFECTIOUS DISEASE REPORTS, 2014, 16 (05) : 1 - 7
  • [40] Antibiotic treatment outcomes in community-acquired pneumonia
    Cilli, Aykut
    Sayiner, Abdullah
    Celenk, Burcu
    Sakar Coskun, Aysin
    Kilinc, Oguz
    Hazar, Armagan
    Aktas Samur, Anil
    Tasbakan, Sezai
    Waterer, Grant W.
    Havlucu, Yavuz
    Kilic, Oznur
    Tokgoz, Fatma
    Bilge, Ugur
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2018, 48 (04) : 730 - 736